A STUDY OF THE EXPRESSION OF THE SARCOPLA SMIC-RETICULUM CALCIUM-ATPASE GENE IN THE LEFT-VENTRICLE OF THE SHEEPS FETUS SUBMITTED TO CHRONICINCREASED AFTERLOAD IN-UTERO

Citation
N. Bonnet et al., A STUDY OF THE EXPRESSION OF THE SARCOPLA SMIC-RETICULUM CALCIUM-ATPASE GENE IN THE LEFT-VENTRICLE OF THE SHEEPS FETUS SUBMITTED TO CHRONICINCREASED AFTERLOAD IN-UTERO, Archives des maladies du coeur et des vaisseaux, 90(5), 1997, pp. 699-705
Citations number
22
Categorie Soggetti
Cardiac & Cardiovascular System","Peripheal Vascular Diseas
ISSN journal
00039683
Volume
90
Issue
5
Year of publication
1997
Pages
699 - 705
Database
ISI
SICI code
0003-9683(1997)90:5<699:ASOTEO>2.0.ZU;2-H
Abstract
The messenger RNA of the cardiac sarcoplasmic reticulum ATP-ase (SERCA -2a) increases in the left ventricle (LV) during ontogenic development but decreases in hypertrophy induced by increased afterload. Because of the frequency of increased left ventricular overload in congenital heart disease, the authors investigated to see if these increases were likely to interfere with the normal ontogenic program of expression o f the SERCA-2a gene in the LV of sheep's foetus. A preductal coarctati on of the aorta was realised by banding the transverse aorta (AoT) at 93 days' gestation in 9 foetus (CoA) matched with 9 healthy twin foetu s (T). All the foetus underwent haemodynamic, anatomical, histological and molecular biological investigations 4 weeks later. The concentrat ion of SERCA-2a mRNA in the LV was measured by hybridation of a Northe rn blot with a rat DNAc probe normalised with RNAr 18S. A coarctation was observed in all the CoA group and in none of the T. The ratio of L V weight/body weight was increased in 65 % of CoA (p <0.0001). The con centration of SERCA-2a mRNA in the LV was much reduced in CoA (average -28.6 %) of the values observed in T (p = 0.003). Left ventricular hy pertrophy of the sheep's foetus induced by pathological increases of a fterload surpassed or slowed down the physiological ontogenic maturati on of expression of the SERCA-2a gene in abnormalities of cardiac pump function.